Chanin Vongkusolkit - Erawan Director
| ERW Stock | THB 4.72 0.10 2.07% |
Director
Mr. Chanin Vongkusolkit is Chairman of the Board of Erawan Group PCL. He is Member of the Investment Committee and Member of the Nominating and Corporationrationrate Governance Committee of the Company. He has a Bachelor degree in Economics from Thammasat University, Thailand, and a MBA in Finance from St. Louis University, the United States. since 2018.
| Age | 64 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | 66 2 257 4588 |
| Web | https://www.theerawan.com |
Erawan Management Efficiency
The company has return on total asset (ROA) of (0.0123) % which means that it has lost $0.0123 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1232) %, meaning that it generated substantial loss on money invested by shareholders. Erawan's management efficiency ratios could be used to measure how well Erawan manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sriphop Sarasat | Bangkok Dusit Medical | 58 | |
| Vinit Tangnoi | Gulf Energy Development | 68 | |
| Narong Chearavanont | CP ALL Public | 54 | |
| Weerawong Chittmittrapap | Bangkok Dusit Medical | 62 | |
| Adirek Sripratak | CP ALL Public | 73 | |
| Wiset Wisitwinyu | CP ALL Public | 57 | |
| Kasem Snidvongs | Gulf Energy Development | 80 | |
| Sansiri Sornmani | Bangkok Dusit Medical | 80 | |
| Wannapa Pawavech | Bangkok Dusit Medical | N/A | |
| Chotikul Sookpiromkasem | Gulf Energy Development | 43 | |
| Thongchai Chirolongkorn | Bangkok Dusit Medical | 55 | |
| Chavalit Sethameteekul | Bangkok Dusit Medical | 71 | |
| Raweporn Kuhirun | Gulf Energy Development | 75 | |
| Phornsiri Manoharn | Bangkok Dusit Medical | 66 | |
| Sommai Phasee | Gulf Energy Development | 74 | |
| Umroong Sanphasitvong | CP ALL Public | 66 | |
| Prasert Jarupanich | CP ALL Public | 70 | |
| Prasoet Charuphanit | CP ALL Public | 66 | |
| Prasobsook Boondech | CP ALL Public | 72 | |
| Thongchai Jiraalongkorn | Bangkok Dusit Medical | 59 | |
| Sombat Uthaisang | Bangkok Dusit Medical | 78 | |
Management Performance
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0123 |
Erawan Group Leadership Team
Elected by the shareholders, the Erawan's board of directors comprises two types of representatives: Erawan inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Erawan. The board's role is to monitor Erawan's management team and ensure that shareholders' interests are well served. Erawan's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Erawan's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Navarat Tamsuwan, Ex Division | ||
| Banyong Pongpanich, Independent Director | ||
| Woramon Inkatanuvat, Ex CFO | ||
| Apichan Mapaisansin, Exec Division | ||
| Chanin Vongkusolkit, Director | ||
| Manop Bongsadadt, Independent Director | ||
| Petch Krainukul, Senior Vice President Director | ||
| Sansern Wongchaum, Independent Director | ||
| Kanokwan Thongsiwarugs, Company Secretary | ||
| Panida Thepkanjana, Director | ||
| Gavin Vongkusolkit, Director | ||
| Dej Bulsuk, Independent Director | ||
| Det Bunsuk, Independent Director | ||
| Youssef Khomri, Ex Division | ||
| Ekasith Jotikasthira, Independent Director | ||
| Kamonwan Wipulakorn, President Director | ||
| Kulpatra Sirodom, Independent Director | ||
| Supol Wattanavekin, Director | ||
| Prakit Pradipasen, Chairman of the Board, Independent Director | ||
| Jetiya Kitiyodom, Assistant Department | ||
| Vitoon Vongkusolkit, Director | ||
| Prakit Prathipasen, Chairman of the Board, Independent Director | ||
| Manop Phongsathat, Independent Director |
Erawan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Erawan a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0123 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.12) % | |||
| Current Valuation | 33.48 B | |||
| Shares Outstanding | 4.53 B | |||
| Shares Owned By Insiders | 54.89 % | |||
| Shares Owned By Institutions | 7.89 % | |||
| Price To Earning | 30.21 X | |||
| Price To Book | 3.65 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Erawan in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Erawan's short interest history, or implied volatility extrapolated from Erawan options trading.
Pair Trading with Erawan
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Erawan position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erawan will appreciate offsetting losses from the drop in the long position's value.Moving against Erawan Stock
| 0.6 | TOP | Thai Oil Public | PairCorr |
| 0.59 | PTT | PTT Public | PairCorr |
| 0.54 | PTTGC | PTT Global Chemical | PairCorr |
| 0.51 | AOT | Airports of Thailand | PairCorr |
| 0.49 | LRH | Laguna Resorts Hotels | PairCorr |
The ability to find closely correlated positions to Erawan could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Erawan when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Erawan - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Erawan Group to buy it.
The correlation of Erawan is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Erawan moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Erawan Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Erawan can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in The Erawan Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Erawan Stock analysis
When running Erawan's price analysis, check to measure Erawan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Erawan is operating at the current time. Most of Erawan's value examination focuses on studying past and present price action to predict the probability of Erawan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Erawan's price. Additionally, you may evaluate how the addition of Erawan to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |